Mgr. Veronika Navrkalová, Ph.D.
Senior researcher, Šárka Pospíšilová Research Group
Office: bldg. E35/218
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 7945 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 113
2014
-
Incorporation of next-generation sequencing into ATM gene analysis in patients with CLL and MCL.
Year: 2014, type: Conference abstract
-
Molekulární prognostické markery chronické lymfocytární leukemie a význam sekvenování nové generace při studiu patogeneze onemocnění
Year: 2014, type: Conference abstract
-
Prognostic impact of NOTCH1 hotspot mutation in TP53-mutated patients with chronic lymphocytic leukemia
Year: 2014, type: Conference abstract
-
SF3B1 mutations in CLL are associated with a defective DNA damage response
Year: 2014, type: Conference abstract
-
Targeted next-generation sequencing for mutational screening in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation within a clinical setting
Year: 2014, type: Conference abstract
-
Význam mutační analýzy prognostických markerů u chronické lymfocytární leukemie s využitím přístupů další generace sekvenováním
Year: 2014, type: Conference abstract
2013
-
ATM inactivation disturbs ATM-p53 pathway in response to DNA damage induced by doxorubicin but not fludarabine in CLL cells
Year: 2013, type: Conference abstract
-
ATM mutations are mutually exclusive with NOTCH1 mutations in chronic lymphocytic leukemia patients
Year: 2013, type: Conference abstract
-
ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin
Haematologica, year: 2013, volume: 98, edition: 7, DOI
-
Mutace genu ATM narušují aktivaci p53 dráhy po poškození DNA doxorubicinem u pacientů s chronickou lymfocytární leukémií: využití pro funkční test
Year: 2013, type: Conference abstract